PODD as reported
Insulet Corporation reported $3.05B of revenue over the trailing twelve months, +29% on the year before. 11 reported series are charted on this page, each one as filed.
$3.05B
Revenue, trailing twelve months · to Q2 2026 · +29% against the twelve months before
- Net Income
- $375M
Net Income · +59% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $294M
Free Cash Flow · −27% year on year · trailing twelve months to Q2 2026
- Op Margin
- 17%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $3.05B | +29% | Q2 2026 |
| Net Income | $375M | +59% | Q2 2026 |
| EPS | $5.34 | +63% | Q2 2026 |
| Gross Margin | 71% | n/a | Q2 2026 |
| Op Margin | 17% | n/a | Q2 2026 |
| Net Margin | 12% | n/a | Q2 2026 |
| ROE | 21% | n/a | Q2 2026 |
| ROA | 9.5% | n/a | Q2 2026 |
| ROIC | 22% | n/a | Q2 2026 |
| Free Cash Flow | $294M | −27% | Q2 2026 |
| P/E | 26.9 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Insulet Corporation (PODD) - Revenue & ProfitRevenue & ProfitInsulet Corporation (PODD)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com